Lymphoid chemokines in chronic neuroinflammation

Journal of Neuroimmunology

Volumn 198, Issue 1-2, 2008, Pages 106-112

  Aloisi, Francesca ^a   Columba Cabezas, Sandra ^a   Franciotta, Diego ^b   Rosicarelli, Barbara ^a   Magliozzi, Roberta ^c   Reynolds, Richard ^c   Ambrosini, Elena ^a   Coccia, Eliana ^a   Salvetti, Marco ^d   Serafini, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemokines; Epstein Barr virus; Inflammation; Lymphoid neogenesis; Multiple sclerosis

Indexed keywords

CXCL13 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; B LYMPHOCYTE; EPSTEIN BARR VIRUS; INFLAMMATION; LYMPHOID TISSUE; MULTIPLE SCLEROSIS; NEUROINFLAMMATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHEMOKINE CXCL13; CHEMOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; LYMPHOCYTES;

EID: 47249163192     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.04.025     Document Type: Article

References (67)

1. Allen C.D., Ansel K.M., Low C., Lesley R., Tamamura H., Fujii N., and Cyster J.G. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5 (2004) 943-952
2. Aloisi F., and Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6 (2006) 205-217
3. Alt C., Laschinger M., and Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 32 (2002) 2133-2144
4. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., and Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41 (2003) 290-300
5. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., Aloisi F., and Coccia E.M. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64 (2005) 706-715
6. Ansel K.M., Ngo V.N., Hyman P.L., Luther S.A., Förster R., Sedgwick J.D., Browining J.L., Lipp M., and Cyster J.G. A chemokine driven positive feedback loop organizes lymphoid follicles. Nature 406 (2000) 309-314
7. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosi. Part I: the role of infection. Ann. Neurol. 61 (2007) 288-299
8. Bagaeva L.V., Rao P., Powers J.M., and Segal B.M. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 7676-7685
9. Bielecki B., Mazurek A., Wolinski P., and Glabinski A. Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE. Scand. J. Immunol. 66 (2007) 383-392
10. Browning J.L., Sizing I.D., Lawton P., Bourdon P.R., Rennert P.D., Majeau G.R., Ambrose C.M., Hession C., Miatkowski K., Griffiths D.A., Ngam-ek A., Meier W., Benjamin C.D., and Hochman P.S. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 159 (1997) 3288-3298
11. Brunn A., Montesinos-Rongen M., Strack A., Reifenberger G., Mawrin C., Schaller C., and Deckert M. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathol. 114 (2007) 271-276
12. Campbell D.J., Kim C.H., and Butcher E.C. Chemokines in the systemic organization of immunity. Immunol. Rev. 195 (2003) 58-71
13. Cannella B., Cross A.H., and Raine C.S. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 172 (1990) 1521-1524
14. Carlsen H.S., Baekkevold E.S., Morton H.C., Haraldsen G., and Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104 (2004) 3021-3027
15. Chen S.C., Leach M.W., Chen Y., Cai X.Y., Sullivan L., Wiekowski M., Dovey-Hartman B.J., Zlotnik A., and Lira S.A. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J. Immunol. 168 (2002) 1009-1017
16. Chen S.C., Vassileva G., Kinsley D., Holzmann S., Manfra D., Wiekowski M.T., Romani N., and Lira S.A. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168 (2002) 1001-1008
17. Columba-Cabezas S., Serafini B., Ambrosini E., and Aloisi F. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 13 (2003) 38-51
18. Columba-Cabezas S., Griguoli M., Rosicarelli B., Magliozzi R., Ria F., Serafini B., and Aloisi F. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein. J. Neuroimmunol. 179 (2006) 76-86
19. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., and Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11064-11069 Electroni publication 2004 Jul 19
20. Cupedo T., and Mebius R.E. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin. Immunol. 15 (2003) 243-248
21. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
22. Dijkstra I.M., de Haas A.H., Brouwer N., Boddeke H.W., and Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 54 (2006) 861-872
23. Drayton D.L., Ying X., Lee J., Lesslauer W., and Ruddle N.H. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197 (2003) 1153-1163
24. Drayton D.L., Liao S., Mounzer R.H., and Ruddle N.H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7 (2006) 344-453
25. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005) 485-495
26. Fan L., Reilly C.R., Luo Y., Dorf M.E., and Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164 (2000) 3955-3959
27. Förster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative, chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
28. Fu Y.-X., and Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17 (1999) 399-433
29. Giunti D., Borsellino G., Benelli R., Marchese M., Capello E., Valle M.T., Pedemonte E., Noonan D., Albini A., Bernardi G., Mancardi G.L., Battistini L., and Uccelli A. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73 (2003) 584-590
30. Guseo A., and Jellinger K. The significance of perivascular infiltrations in multiple sclerosis. J Neurol. 211 (1975) 51-60
31. Hjelmström P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69 (2001) 331-339
32. Kivisäkk P., Mahad D.J., Callahan M.K., Sikora K., Trebst C., Tucky B., Wujek J., Ravid R., Staugaitis S.M., Lassmann H., and Ransohoff R.M. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55 (2004) 627-638
33. Kivisäkk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., Wu L., Baekkevold E.S., Lassmann H., Staugaitis S.M., Campbell J.J., and Ransohoff R.M. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8389-8394
34. Kratz A., Campos-Neto A., Hanson M.S., and Ruddle N.H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183 (1996) 1461-1472
35. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader, Monorau C.-A., Kalled, Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohllfeld R., and Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201 (2005) 195-200
36. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., and Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129 (2006) 200-211
37. Krumbholz M., Theil D., Steinmeyer F., Cepok S., Hemmer B., Hofbauer M., Farina C., Derfuss T., Junker A., Arzberger T., Sinicina I., Hartle C., Newcombe J., Hohlfeld R., and Meinl E. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J. Neuroimmunol. 190 (2007) 72-79
38. Lassmann H., Brück W., and Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17 (2007) 210-218
39. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., and Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42 (2003) 139-148
40. Legler D.F., Loetscher M., Roos R.S., Clark-Lewis I., Baggiolini M., and Moser B. B-cell attracting chemokine 1, a human CXC chemokine expressed inlymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187 (1998) 655-660
41. Luther S.A., Lopez T., Bai W., Hanahan D., and Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12 (2000) 471-481
42. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., Matloubian M., and Cyster J.G. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169 (2002) 424-433
43. Lünemann J.D., Kamradt T., Martin R., and Münz C. Epstein Barr virus: environmental trigger for multiple sclerosis?. J. Virol. 81 (2007) 6777-6784
44. Mackay F., and Browning J.L. Turning off follicular dendritic cells. Nature 395 (1998) 26-27
45. Magliozzi R., Columba-Cabezas S., Serafini B., and Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148 (2004) 11-23
46. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Popolo M., Reynolds R., and Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007) 1089-1104
47. Martin A.P., Coronel E.C., Sano G., Chen S.C., Vassileva G., Canasto-Chibuque C., Sedgwick J.D., Frenette P.S., Lipp M., Furtado G.C., and Lira S.A. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 173 (2004) 4791-4798
48. Mazzucchelli L., Blaser A., Kappeler A., Schärli P., Laissue J.A., Baggiolini M., and Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104 (1999) 49-54
49. Moser B., Schaerli P., and Laetscher P. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol. 23 (2002) 250-254
50. Müller G., Höpken U.E., and Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195 (2003) 117-135
51. Narayan K., Dail D., Li L., Cadavid D., Amrute S., Fitzgerald-Bocarsly P., and Pachner A.R. The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann. Neurol. 57 (2005) 813-823
52. Ngo V.N., Korner H., Gunn M.D., Schmidt K.N., Riminton D.S., Cooper M.D., Browning J.L., Sedgwick J.D., and Cyster J.G. Lymphotoxin-α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189 (1999) 403-412
53. Parsonage G., Filer A.D., Haworth O., Nash G.B., Rainger G.E., Salmon M., and Buckley C.D. A stromal address code defined by fibroblasts. Trends Immunol. 26 (2005) 150-156
54. Pashenkov M., Söderström M., and Link H. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J. Neuroimmunol. 135 (2003) 154-160
55. Perrier P., Martinez F.O., Locati M., Bianchi G., Nebuloni M., Vago G., Bazzoni F., Sozzani S., Allavena P., and Mantovani A. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172 (2004) 7031-7042
56. Prineas J.W., and Wright R.G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38 (1978) 409-421
57. Rupprecht T.A., Koedel U., Angele B., Fingerle V., and Pfister H.W. Cytokine CXCL13 - a possible early CSF marker for neuroborreliosis. Nervenarzt 77 (2006) 470-473
58. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., and Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14 (2004) 164-174
59. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., and Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65 (2006) 124-141
60. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Androni L., Trivedi P., Salvetti M., Faggioni A., and Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204 (2007) 2899-2912
61. Smith J.R., Braziel R.M., Paoletti S., Lipp M., Uguccioni M., and Rosenbaum J.T. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 101 (2003) 815-821
62. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1 (2001) 75-82
63. Ticchioni M., Essafi M., Jeandel P.Y., Davi F., Cassuto J.P., Deckert M., and Bernard A. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26 (2007) 7081-7091
64. Tschen S.-I., Stohlman S.A., Ramakrishna C., Hinton D.R., Atkinson R.D., and Bergmann C.C. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur. J. Immunol. 36 (2006) 603-612
65. Uccelli A., Aloisi F., and Pistoia V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 26 (2005) 254-259
66. Yoshie O., Imai T., and Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 62 (1997) 634-644
67. Zlotnik A., Morales J., and Hedrick J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 19 (1999) 1-47